Fonar Corp (FONR)
17.01
+0.25
(+1.49%)
USD |
NASDAQ |
Apr 19, 16:00
17.01
0.00 (0.00%)
After-Hours: 20:00
Fonar Enterprise Value: 47.49M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 47.49M |
| April 17, 2024 | 45.94M |
| April 16, 2024 | 47.68M |
| April 15, 2024 | 47.94M |
| April 12, 2024 | 50.07M |
| April 11, 2024 | 53.17M |
| April 10, 2024 | 55.88M |
| April 09, 2024 | 62.60M |
| April 08, 2024 | 60.34M |
| April 05, 2024 | 65.44M |
| April 04, 2024 | 67.28M |
| April 03, 2024 | 66.53M |
| April 02, 2024 | 68.73M |
| April 01, 2024 | 71.12M |
| March 28, 2024 | 77.19M |
| March 27, 2024 | 79.96M |
| March 26, 2024 | 79.45M |
| March 25, 2024 | 80.35M |
| March 22, 2024 | 83.13M |
| March 21, 2024 | 83.51M |
| March 20, 2024 | 82.80M |
| March 19, 2024 | 75.77M |
| March 18, 2024 | 78.80M |
| March 15, 2024 | 80.61M |
| March 14, 2024 | 82.93M |
| Date | Value |
|---|---|
| March 13, 2024 | 85.97M |
| March 12, 2024 | 87.77M |
| March 11, 2024 | 82.67M |
| March 08, 2024 | 85.52M |
| March 07, 2024 | 88.81M |
| March 06, 2024 | 85.77M |
| March 05, 2024 | 88.61M |
| March 04, 2024 | 87.71M |
| March 01, 2024 | 84.55M |
| February 29, 2024 | 83.06M |
| February 28, 2024 | 87.77M |
| February 27, 2024 | 88.03M |
| February 26, 2024 | 89.32M |
| February 23, 2024 | 86.61M |
| February 22, 2024 | 83.84M |
| February 21, 2024 | 87.71M |
| February 20, 2024 | 87.97M |
| February 16, 2024 | 87.97M |
| February 15, 2024 | 82.42M |
| February 14, 2024 | 81.84M |
| February 13, 2024 | 71.18M |
| February 12, 2024 | 70.73M |
| February 09, 2024 | 72.73M |
| February 08, 2024 | 69.70M |
| February 07, 2024 | 69.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
23.56M
Minimum
Oct 25 2023
138.37M
Maximum
Aug 11 2020
77.32M
Average
70.09M
Median
Enterprise Value Benchmarks
| XWELL Inc | -9.224M |
| ProPhase Labs Inc | 103.69M |
| Applied DNA Sciences Inc | 2.269M |
| Veracyte Inc | 1.225B |
| OncoCyte Corp | 25.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.759M |
| Revenue (Quarterly) | 25.39M |
| Total Expenses (Quarterly) | 20.50M |
| EPS Diluted (Quarterly) | 0.54 |
| Gross Profit Margin (Quarterly) | 42.89% |
| Profit Margin (Quarterly) | 14.81% |
| Earnings Yield | 10.82% |
| Operating Earnings Yield | 16.04% |
| Normalized Earnings Yield | 9.494 |